Imunoterapi dengan Keytruda (Pembrolizumab) Dokter Terbaik di Israel - TOP-23 dokter

Peneliti utama uji klinis dalam terapi kanker – Dr. Sarid membawa keahlian imunoterapi mutakhir ke Sourasky Medical Center.

• Onkolog senior di Ichilov sejak 2009 dengan pengalaman 15+ tahun dalam pengobatan kanker
• Spesialisasi dalam terapi kanker biologis, termasuk aplikasi Keytruda
• Pelatihan di Oxford di bidang urologi kanker dengan 30+ artikel penelitian yang diterbitkan
• Anggota aktif ESMO dan ASCO – standar onkologi global

Dr. Pelles Sharon berspesialisasi dalam imunoterapi dengan Keytruda di Sourasky Medical Center, membawa penelitian luas dan keahlian klinis untuk pengobatan kanker.

• Melakukan penelitian signifikan tentang sikap pasien terhadap uji klinis
• Menawarkan berbagai macam pengobatan kanker tingkat lanjut
• Berpengalaman dalam berbagai prosedur onkologi bedah dan non-bedah
• Bekerja di salah satu pusat medis terkemuka di Israel

Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – pelopor dalam penelitian imunoterapi untuk sarkoma.

• Pengalaman lebih dari 25 tahun mengkhususkan diri dalam pengobatan sarkoma dan imunoterapi
• Anggota fakultas ESMO untuk protokol pengobatan sarkoma
• Telah mempublikasikan secara luas mengenai hasil imunoterapi pada kanker tulang
• Menempuh pelatihan Fellowship di Institut Gustave Roussy – pusat sarkoma terkemuka di Eropa

Dr. Ram Ron berspesialisasi dalam Imunoterapi dengan Keytruda (Pembrolizumab) di Pusat Medis Sourasky (Ichilov), menawarkan opsi perawatan canggih.

• Minat khusus meliputi perawatan imunoterapi mutakhir
• Praktik di pusat medis terkemuka yang dikenal untuk onkologi
• Berfokus pada perawatan yang berpusat pada pasien dengan rencana perawatan yang dipersonalisasi

Lebih dari 300 transplantasi sumsum tulang dan darah tali pusat telah dilakukan – Dr. El Hasid memimpin onkohematologi pediatrik di Rumah Sakit Anak Dana Dwek.

• Kepala Departemen Onkohematologi dan Onkologi Pediatrik
• Anggota Asosiasi Hematologi Amerika (American Association for Hematology)
• 50+ publikasi dan 40 laporan konferensi
• Pelatihan di City of Hope Hospital di Los Angeles

Dr. Ron Ram telah melakukan beberapa ratus transplantasi sel punca dan menerbitkan lebih dari 30 artikel ilmiah, menunjukkan keahliannya yang mendalam di bidang onkologi.

• Bersertifikasi dewan dalam bidang Penyakit Dalam, Hematologi, dan Onkologi Medis
• Menjalani pelatihan subspesialisasi (Fellowship) di New York Medical College, Westchester Medical Center
• Menerbitkan bab dalam buku teks medis
• Bekerja di Pusat Medis Sourasky (Ichilov)

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Peneliti terkemuka dalam uji coba imunoterapi – Dr. Raphael berspesialisasi dalam Keytruda (Pembrolizumab) di Sourasky Medical Center.

• Peneliti utama untuk uji klinis Keytruda pada NSCLC
• Ahli dalam profil genomik dan biopsi cair untuk respons pengobatan
• Anggota Asosiasi Internasional untuk Studi Kanker Paru-paru
• Pengajar luar biasa yang diakui oleh Universitas Tel-Aviv

Kepala Onkologi Medis di Sourasky Medical Center – Dr. Wolf memimpin divisi onkologi terkemuka yang berspesialisasi dalam perawatan canggih.

• Berspesialisasi dalam onkologi dengan pengalaman luas dalam imunoterapi
• Gelar dari Ben Gurion University – terlatih dalam protokol onkologi mutakhir
• Fasih berbahasa Inggris untuk komunikasi pasien yang jelas
• Latar belakang termasuk Unit Medis Angkatan Darat – menangani kasus-kasus kompleks

Kepala Klinik Neuroonkologi di Sourasky Medical Center (Ichilov) – berspesialisasi dalam pengobatan kanker tingkat lanjut.

• Memimpin tim yang berdedikasi untuk kasus neuroonkologi
• Fokus pada terapi inovatif seperti imunoterapi
• Bekerja di salah satu pusat medis terkemuka di Israel

Direktur rawat inap onkologi di Tel Aviv Medical Center, Ichilov – Dr. Stepfansky membawa keahlian klinis dan penelitian yang ekstensif pada kasus-kasus imunoterapi.

• Lebih dari 20 tahun pengalaman dalam onkologi dan penyakit dalam
• Terlibat aktif dalam uji klinis Fase I-III untuk pengobatan kanker baru
• Pelatihan khusus di bidang onkologi dari Tel Aviv Medical Center, Ichilov
• Memegang berbagai peran penelitian dalam studi imunoterapi mutakhir

Dr. Fredi Aviv membawa 31 tahun keahlian onkohematologi untuk perawatan imunoterapi di Sourasky Medical Center (Klinik Ichilov).

• Spesialisasi dalam onkologi hematologi dan imunoterapi
• Berpraktik di pusat medis terkemuka di Israel
• Pengalaman luas dengan perawatan kanker mutakhir

Direktur hematologi onkologi anak di Sourasky Medical Center, berspesialisasi dalam kanker tulang (sarkoma) dan kelainan darah.

• Dokter anak senior di Rumah Sakit Anak 'Dana'
• Berspesialisasi dalam hematologi dan onkologi pediatrik
• Anggota asosiasi Israel ISPHO
• Menempuh studi onkologi tulang dan jaringan lunak di Rizzoli Orthopaedic Institute, Italia

Dr. Yair berspesialisasi dalam hematologi dengan fokus pada leukemia limfositik kronis – diakui dengan berbagai penghargaan atas penelitian dan keunggulan klinisnya.

• Penerima Klitzberg Oncology Award dan penghargaan bergengsi lainnya
• Anggota Asosiasi Hematologi Israel dan Amerika
• Pelatihan di pusat medis terkemuka di Israel
• Publikasi luas dalam penelitian hematologi

Dr. Sonnenblick Amir berspesialisasi dalam terapi bertarget untuk kanker payudara, termasuk imunoterapi dengan Keytruda (Pembrolizumab). Beliau diakui dengan berbagai penghargaan atas kontribusinya pada penelitian onkologi.

• Beasiswa Penelitian Klinis dan Translasi Kanker Payudara ESMO di Jules Bordet Institute
• Lebih dari 30 presentasi pada pertemuan ilmiah nasional dan internasional
• Penerima Penghargaan Penelitian Translasi Kanker Payudara ESMO
• Anggota Masyarakat Onkologi Medis Eropa (ESMO)

Dr. Auala Hubert memiliki 33 tahun keahlian dalam bidang onkologi dan radioterapi di Hadassah Medical Center, berspesialisasi dalam imunoterapi.

• Memimpin Pusat Kanker Gastrointestinal – keahlian mendalam dalam kasus-kasus kompleks
• Menjalani pelatihan di Rumah Sakit Universitas Hadassah – salah satu pusat onkologi terkemuka di Israel
• Anggota aktif dari berbagai komite penelitian dan pengobatan kanker

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.